ArticleCancer research communications2026

Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer.

Annie Blair Richardson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.